Skip to main content

Table 4 Clinical failures (CF) by day 42, 63 and 90 post-treatment, by clinical outcome at day 28 and treatment group

From: Extended high efficacy of the combination sulphadoxine-pyrimethamine with artesunate in children with uncomplicated falciparum malaria on the Benin coast, West Africa

Outcome at D28° Treatment group
(N) 		CF Total CF
D29-90
  D7-28 D29-42 D43-63 D64-90
ACPR
(n = 123) 		SP-AS R 0 0 0 0 0
  68 N 0 0 2 5 7
  CQ R 0 1 0 0 1
  18 N 0 1 0 0 1
  SP 37 R 0 1 0 2 3
  37 N 0 0 0 1 1
LPF new infection
(n = 7) 		SP-AS R 0 0 0 0 0
  4 N 0 1 0 0 1
  CQ R 0 0 0 0 0
  2 N 0 0 0 0 0
  SP R 0 0 0 0 0
  1 N 0 0 0 1 1
LPF recrudescence
(n = 38) 		SP-AS R 0 0 1 0 1
  3 N 0 0 0 0 0
  CQ R 3 0 0 0 3
  25 N 0 0 1 2 3
  SP R 4 0 0 0 4
  10 N 0 0 0 0 0
  1. °ACPR: Adequate Clinical and Parasitological Response;
  2. LPF: Late Parasitological Failure; R = recrudescence; N = new infection; D = day).
Back to article page